Hedge funds

Keeping one step ahead of the innovators

Kilkenny Capital Management has been making healthy returns out of the biotechnology sector for more than a decade. Jay Blanche met up with the top brass while they were in London, to find out how they do it

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here